Nima Mosammaparast

15PUBLICATIONS
99CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsMicroelectromechanical systems (MEMS)Cancer therapy (excl. chemotherapy and radiation therapy)Industrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 10, 2026
Human MutLα activates methylpurine DNA glycosylase to induce alkylation damage cytotoxicity.

|Jan 02, 2026
DNA-damaging chemotherapy reshapes cardiac-resident macrophage composition and function.

Ruijun He, Farid F Kadyrov, Andrew L Koenig

|Dec 25, 2025
Human MutLα activates methylpurine DNA glycosylase to induce alkylation damage cytotoxicity.

Mohamed E Ashour, Ellissa Krekeler, Monika Chandan Bhowmik

|Oct 08, 2025
CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.

Ji Geng, Xiying Wang, Jie Pan

|May 30, 2024
TCAF1 promotes TRPV2-mediated Ca2+ release in response to cytosolic DNA to protect stressed replication forks.

Lingzhen Kong, Chen Cheng, Abigael Cheruiyot

|May 30, 2024
The debranching enzyme Dbr1 regulates lariat turnover and intron splicing.

Luke Buerer, Nathaniel E Clark, Anastasia Welch

Pageof 3

Frequent Collaborators

2 joint publications

Andrea K Byrum

2 joint publications

Masad J Damha

2 joint publications

Chien-Ling Lin

2 joint publications

Stephen Rong